Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
(NQ: )
N/A   UNCHANGED
Last Price  /  Updated:   /  Add to My Watchlist      
View: Quote News
Blog posts about
 
Alexza Pharmaceuticals, Inc. (NASDAQ:ALXA) Investor Alert: Investigation over Potential Violations of Securities Laws
May 09, 2012
San Diego, CA -- (SBWIRE) -- 05/09/2012 -- An investigation on behalf of investors of NASDAQ:ALXA shares over possible securities laws violations by Alexza Pharmaceuticals, Inc. was announced and... Read More
from SBWire - Latest Press Releases
Hot Option Plays: Data Disappoints
May 04, 2012
Cusick’s Corner 05-04-2012 The data was worse than expected and the market reacted negatively — the momentum appears to be on the side of the shorts. The overall market positioning appears to be more... Read More
category RIMM , LNKD , F , and 11 more.
from DailyMarkets.com
Hot Option Plays: A Day At The Range
March 07, 2012
Cusick’s Corner 03-07-2012 Nice bounce into the Midday but not the conviction, i.e. light volume, that would show that this is a one and done pullback. We are now in a trading area called “no man’s... Read More
category Options , yhoo , kft , and 12 more.
from DailyMarkets.com
Alexza Pharmaceuticals (Nasdaq: ALXA): FDA Committee Recommends Approval of ADASUVE
December 13, 2011
Palm Beach, FL - December 13, 2011 (Investorideas.com Newswire) - The Street Beat commentary - Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today that the Psychopharmacologic Drugs Advisory... Read More
category NASDAQ:ALXA
from Investorideas.com newswire, stock news and business news for investors
Highs & Lows: Alexza Pharmaceuticals and Madison Square Garden
December 08, 2011
The major market indexes have spent the session swimming in red ink, so it's no surprise to find that new lows have outnumbered new highs on the Nasdaq...( Read More ) Read More
category ALXA
from SchaeffersResearch.com Trading Floor Blog
Week of 11/11/11, AKA Doomsday
November 07, 2011
from Wall Street Greek
(ALXA) Company News for October 5, 2011 – Corporate Summary
October 06, 2011
• Drug developer Transcept Pharmaceuticals Inc.’s (NASDAQ:TSPT) shares increased 33.77% to close... Visit StockBlogHub to view complete post. Read More
category S , Transcept Pharmaceuticals Inc , Red Hat Inc/ , and 15 more.
from Stock Blog Hub
Up/Downgrades (ALXA, ANDS, EQR, EXC, IVR, AMED, PPDI, QSII)
October 04, 2011
New York, October 4th (TradersHuddle.com) – Following are some of other top upgrades and downgrades before the market open. Upgrades Alexza Pharmaceuticals (<a hr. Read More -- Read More
from TradersHuddle.com
Standard and Poor’s Worst Mistake Yet
August 08, 2011
category Week/Ahead , Rating/Agencies , Editors/Picks , and 1 more.
from Wall Street Greek
Top Stocks that others ignore and Wall Street turns a blind eye
June 10, 2011
Baseball players, William Henry Keeler’s advice to hitters was “Keep your eye clear, and hit ‘em where they ain’t”. They same rule applies in market as well, here we will see few Top Stocks that others... Read More
category LNKD , JASO , VRX , and 35 more.
from CEOWORLD Magazine
K-V Pharmaceutical (NYSE: KV-A) – Catches a Spark to a 42% Gain
May 27, 2011
category Biotechnology , Health/Care/Sector , KV/A , and 5 more.
from Wall Street Greek
Weekly Business Calendar
May 09, 2011
from Wall Street Greek
(ALXA) Alexza Pharmaceuticals – Bull of the Day
March 17, 2011
We are upgrading our rating on shares of Alexza Pharmaceuticals (ALXA) to Outperform and raising our price target to $3 per share. We believe the company is on track to re-file the new drug application... Read More
category Healthcare , ALXA , Drug Manufacturers / Other , and 1 more.
from Stock Blog Hub
Bull Of The Day: Alexza Pharmaceuticals (ALXA)
March 17, 2011
We are upgrading our rating on shares of Alexza Pharmaceuticals (NASDAQ:ALXA) to Outperform and raising our price target to $3 per share. We believe the company is on track to re-file the new drug... Read More
category ALXA , Stocks , External Research , and 1 more.
from DailyMarkets.com
Citigroup, Delta, Boeing… traded heavily on Tuesday- C, DAL, BA, CMA, FRX, MTH, NVDA, ALXA
January 19, 2011
Citigroup Inc. (C) , down 33 cents at $4.80- The bank turned its first annual profit since 2007, but its quarterly results fell short of Wall Street analysts’ estimates. Citigroup, Inc., a global... Read More
category Mobile Devices , Finance , aircraft maker , and 45 more.
from CEOWORLD Magazine
Cypress Bio Gives In To Ramius
December 17, 2010
After months of wooing Cypress Bioscience (NASDAQ:CYPB), Ramius LLC finally has reached an agreement with Cypress Bio’s board. Cypress Bio entered into a definitive merger with Ramius V&O Acquisition... Read More
category FRX , ALXA , MRNA , and 5 more.
from DailyMarkets.com
An Update On Alexza Pharma (ALXA)
December 03, 2010
Jason Napodano, CFA On October 10, 2010, the U.S. FDA issued a complete response letter (CRL) on the approval of AZ-004 (Staccato loxapine) for the rapid treatment of agitation in patients with... Read More
category Stocks , External Research , Contributor
from DailyMarkets.com
(CYPB) Cypress Bioscience Reports Wider Loss
November 25, 2010
Cypress Bioscience, Inc. (CYPB) reported a net loss of 94 cents per share in the third quarter, significantly higher than the Zacks Consensus Estimate of a loss of 33 cents and the year ago loss of 12... Read More
category Biotechnology , FRX , CNS , and 9 more.
from Stock Blog Hub
Wider Loss At Cypress Bio
November 17, 2010
Cypress Bioscience, Inc. (NASDAQ:CYPB) reported a net loss of 94 cents per share in the third quarter, significantly higher than the Zacks Consensus Estimate of a loss of 33 cents and the year ago loss... Read More
category FRX , ALXA , MRNA , and 5 more.
from DailyMarkets.com
Upgrades and Downgrades (AXP, CP, ESS, ALXA, AEP, DVA, JAZZ, KLIC, VZ, WAC, WYNN)
October 12, 2010
New York, October 12th (TradersHuddle.com) – Following are some of the top upgrades and downgrades before the market open. Upgrades American Express (NYSE:AXP), t. Read More -- Read More
from TradersHuddle.com
FDA Delays Alexza’s Adusuve
October 11, 2010
This morning the U.S. FDA issued a complete response letter (CRL) to Alexza Pharmaceuticals (NASDAQ:ALXA) on the approval of Adusuve Staccato (formerly AZ-004, Staccato loxapine) for the rapid... Read More
category USA , ALXA , Stocks , and 2 more.
from DailyMarkets.com
Cypress Bio Sells Diagnostics Biz
October 11, 2010
Cypress Bioscience, Inc. (NASDAQ:CYPB) recently disclosed its agreement with Exagen Diagnostics, Inc. for the sale of its diagnostics business for up to $8 million.   Earlier this year, Cypress Bio had... Read More
category USA , ALXA , Stocks , and 3 more.
from DailyMarkets.com
Columbus Day - Stock Market Open
October 11, 2010
from Wall Street Greek
Wall Street News Preview 09-27-10
September 27, 2010
from Wall Street Greek
(CYPB) Cypress Bioscience Signs Deal With Marina Biotech
September 16, 2010
Recently, Cypress Bioscience, Inc. (CYPB) announced that it has inked a deal with Marina Biotech, Inc. (MRNA). The deal, which allows Cypress to acquire Marina’s patent rights and technology for autism... Read More
category Biotechnology , CNS , ALXA , and 7 more.
from Stock Blog Hub
Cypress Bioscience Inks Deal
August 30, 2010
Recently, Cypress Bioscience, Inc. (NASDAQ:CYPB) announced that it has inked a deal with Marina Biotech, Inc. (NASDAQ:MRNA). The deal, which allows Cypress to acquire Marina’s patent rights and... Read More
category USA , ALXA , Stocks , and 5 more.
from DailyMarkets.com
Trading FDA, Clinical Trial Binary Events: $AFFY $ALXA $INCY $PGNX (ALXA, rated BUY)
August 05, 2010
Below are some Regulatory Catalyst Index updates for companies with recent FDA and clinical trial related news... <font> Affymax (NASDAQ:AFFY) and partner Takeda Pharma (OTC:TKPHY) reported that... Read More
category Healthcare , Biotechnology & Drugs
from SocialPicks.com: Front Page Picks
This Week: GDP & Consumer Confidence Rangel
July 27, 2010
from Wall Street Greek
Chicago Fed National Activity Index June 2010
July 26, 2010
from Wall Street Greek
Bull Of The Day: Alexza Pharmaceuticals (ALXA)
July 19, 2010
Alexza Pharmaceuticals (NASDAQ:ALXA) provided an update on the pipeline earlier this week. Management has selected AZ-007 as the next candidate to move forward. AZ-007 (Staccato zaleplon) will be... Read More
category USA , ALXA , Stocks , and 3 more.
from DailyMarkets.com
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here